Lv6
3030 积分 2023-02-22 加入
Assessment of estimated glomerular filtration rate in patients with chronic myeloid leukemia following discontinuation of tyrosine kinase inhibitors
4天前
已完结
Nephrotoxicity in cancer treatment: An update
7天前
已完结
Renal Toxicities of Targeted Therapies
8天前
已完结
Effect of tyrosine kinase inhibitors on renal handling of creatinine by MATE1
8天前
已完结
Assessment of chronic renal injury in patients with chronic myeloid leukemia in the chronic phase receiving tyrosine kinase inhibitors
8天前
已完结
pharmacology of Tyrosine Kinase Inhibitors Implications for Patients with Kidney Diseases
17天前
已完结
Sonrotoclax: First Approval
19天前
已完结
The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy
20天前
已完结
Bortezomib in combination with dose-adjusted EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) induces long-term survival in patients with plasmablastic lymphoma: a retrospective analysis
25天前
已完结
Effect of Tyrosine Kinase Inhibitor Therapy on Estimated Glomerular Filtration Rate in Patients with Chronic Myeloid Leukemia
27天前
已完结
皖公网安备34019202002308
